Matt Hollingsworth and Andrew Shin

Matt Hollingsworth is the CEO and co-founder of Carta Healthcare, provider of AI-powered clinical data abstraction technology and services. Matt holds an MBA from Stanford University and studied high-energy physics, performing his research at CERN (European Organization for Nuclear Research) as part of the team that discovered the Higgs boson. Prior to CERN, Matt co-founded a technology startup, Global Dressage Analytics, and provided technical leadership for another startup, Deepfield, which provides telecom analytics. He also proposed, won, and managed projects for the Department of Defense and managed projects for various Internet of Things (IoT) applications at Samsung.

Andrew Shin, MD, is a Clinical Professor of Cardiology at Lucile Packard Children’s Hospital at Stanford University and the Executive Medical Director, Innovations & Clinical Effectiveness for Stanford Children’s Health. His research has leveraged microsystems, improvement science and principles of high-reliability organizations to better understand the intersection between the quality and efficiency of healthcare delivery. As the Medical Director for Systems Design for Utilization Research for Stanford (SURF MEDICINE), Dr. Shin translates his research to improve the value of healthcare utilizing high-throughput advanced analytics such as machine learning and artificial intelligence. He completed his pediatric residency and dual fellowship in pediatric cardiology and pediatric critical care at Boston Children’s Hospital. Dr. Shin is the Associate Medical Director for Cardiovascular Intensive Care Services and serves as a board member for Pediatric Congenital Heart Association, Carta Healthcare, and as liaison for the American Heart Association’s Leadership Committee of the Council on Quality of Care and Outcomes Research.

Posts by Matt Hollingsworth and Andrew Shin